Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Kenvue Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

SUMMIT, N.J.--(BUSINESS WIRE)--KENVUE INC. (NYSE: KVUE) TODAY ANNOUNCED FINANCIAL RESULTS FOR THE FISCAL FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 28, 2025. WE ENDED 2025 WITH STRONGER TOP- AND BOTTOM-LINE PERFORMANCE IN THE FOURTH QUARTER, WHICH REFLECTED BOTH DISCIPLINED EXECUTION AGAINST OUR STRATEGIC PRIORITIES, AS WELL AS A MORE FAVORABLE YEAR-AGO COMPARISON ON SALES, SAID KIRK PERRY, CHIEF EXECUTIVE OFFICER. AS WE LOOK TO 2026, WE REMAIN FOCUSED ON CONTINUING TO ENHANCE OUR PERFORMAN.

KENVUE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

SUMMIT, N.J.--(BUSINESS WIRE)--KENVUE INC. (NYSE: KVUE) WILL ANNOUNCE ITS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AFTER MARKET CLOSE ON FEBRUARY 17, 2026. DUE TO THE PENDING TRANSACTION WITH KIMBERLY-CLARK, KENVUE WILL NOT BE HOSTING A QUARTERLY CONFERENCE CALL TO REVIEW ITS FINANCIAL RESULTS. THE PRESS RELEASE WILL BE AVAILABLE ON THE COMPANY'S WEBSITE AT INVESTORS.KENVUE.COM. ABOUT KENVUE KENVUE INC. IS THE WORLD'S LARGEST PURE-PLAY CONSUMER HEALTH COMPANY BY REVENUE. BUILT ON MOR.

KENVUE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2025 RESULTS ON FEBRUARY 17, 2026

KEY MILESTONE IN CREATING A GLOBAL HEALTH AND WELLNESS LEADER TRANSACTION EXPECTED TO CLOSE IN THE SECOND HALF OF 2026 DALLASAND SUMMIT, N.J., JAN. 29, 2026 /PRNEWSWIRE/ --KIMBERLY-CLARK CORPORATION (NASDAQ: KMB) AND KENVUE INC. (NYSE: KVUE) TODAY ANNOUNCED THAT KIMBERLY-CLARK AND KENVUE SHAREHOLDERS VOTED OVERWHELMINGLY TO APPROVE ALL OF THE PROPOSALS NECESSARY FOR KIMBERLY-CLARK TO COMPLETE ITS ACQUISITION OF KENVUE AT THEIR RESPECTIVE SPECIAL MEETINGS OF STOCKHOLDERS HELD TODAY.

KIMBERLY-CLARK AND KENVUE SHAREHOLDERS OVERWHELMINGLY APPROVE KIMBERLY-CLARK'S ACQUISITION OF KENVUE

SUMMIT, N.J.--(BUSINESS WIRE)--KENVUE INC. (NYSE: KVUE) TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS DECLARED A QUARTERLY DIVIDEND OF $0.2075 PER SHARE ON ITS COMMON STOCK. THE QUARTERLY DIVIDEND IS PAYABLE ON FEBRUARY 25, 2026, TO SHAREHOLDERS OF RECORD AS OF THE CLOSE OF BUSINESS ON FEBRUARY 11, 2026. ABOUT KENVUE KENVUE INC. IS THE WORLD'S LARGEST PURE-PLAY CONSUMER HEALTH COMPANY BY REVENUE. BUILT ON MORE THAN A CENTURY OF HERITAGE, OUR ICONIC BRANDS, INCLUDING AVEENO, BAND-AID BRAND, JOHN.

KENVUE DECLARES QUARTERLY CASH DIVIDEND

NEW YORK AND NEW ORLEANS, JAN. 7, 2026 /PRNEWSWIRE/ -- FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ.

KENVUE INVESTOR ALERT: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF KENVUE INC. - KVUE

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND THE LAW FIRM OF KAHN SWICK & FOTI, LLC (KSF) ARE INVESTIGATING THE PROPOSED SALE OF KENVUE INC. (NYSE: KVUE) TO KIMBERLY-CLARK CORPORATION (NASDAQGS: KMB). UNDER THE TERMS OF THE PROPOSED TRANSACTION, SHAREHOLDERS OF KENVUE WILL RECEIVE $3.50 IN CASH PLUS 0.14625 KIMBERLY-CLARK SHARES FOR EACH SHARE OF KENVUE THAT THEY OWN. KSF IS SEEKING TO DETERMINE WHETHER THIS CONSIDERATIO.

KENVUE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF KENVUE INC. - KVUE

SUMMIT, N.J.--(BUSINESS WIRE)--KENVUE INC. (NYSE: KVUE) TODAY ANNOUNCED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 28, 2025. THROUGHOUT THE THIRD QUARTER, OUR TEAM REMAINED FOCUSED ON OUR FOUR OPERATING PRIORITIES TO DRIVE IMPROVED PERFORMANCE, SAID KIRK PERRY, CHIEF EXECUTIVE OFFICER. THIRD QUARTER RESULTS KEEP US ON TRACK TO DELIVER OUR FULL YEAR GUIDANCE AND WE ARE CONFIDENT IN THE DECISIVE ACTIONS WE ARE TAKING TO ACCELERATE KENVUE'S PERFORMANCE AND UNLOCK THE INHERENT VALUE.

KENVUE REPORTS THIRD QUARTER 2025 RESULTS

COMBINES HIGHLY COMPLEMENTARY AND STRATEGICALLY ALIGNED CONSUMER OFFERINGS, INCLUDING 10 ICONIC BILLION-DOLLAR BRANDS, THAT WILL PROVIDE PREFERRED SOLUTIONS THROUGH EVERY STAGE OF LIFE APPLIES KIMBERLY-CLARK'S PROVEN COMMERCIAL EXECUTION PLAYBOOK TO CREATE A BEST-IN-CLASSCONSUMER-DRIVEN COMPANY ACCELERATES KENVUE'S PREMIER CONSUMER HEALTH PORTFOLIO AND STRONG SCIENCE-BACKED INNOVATION, SUPPORTED BY TALENTED KENVUE TEAM ENHANCES INVESTMENT IN MARKETING, INNOVATION AND R&D CAPABILITIES TO STRENGTHENCOMBINED COMPANY'S UNIQUE ADVANTAGES TOTAL ANTICIPATED RUN-RATE SYNERGIES OF $2.1 BILLION; EXPECTED TO BE ACCRETIVE TOKIMBERLY-CLARK'S ADJUSTED EPS BY YEAR 2 DELIVERS IMMEDIATE UPFRONT VALUE TO KENVUE SHAREHOLDERS, WITH OPPORTUNITY TO PARTICIPATE IN SIGNIFICANT FUTURE UPSIDE FROM COMBINED VALUE CREATION COMPANIES TO HOST JOINT INVESTOR CONFERENCE CALL TODAY AT 8:00 AM ET DALLAS AND SUMMIT, N.J. , NOV. 3, 2025 /PRNEWSWIRE/ -- KIMBERLY-CLARK CORPORATION (NASDAQ: KMB), A GLOBAL PERSONAL CARE LEADER, AND KENVUE INC. (NYSE: KVUE), A GLOBAL CONSUMER HEALTH LEADER, TODAY ANNOUNCED AN AGREEMENT UNDER WHICH KIMBERLY-CLARK WILL ACQUIRE ALL OF THE OUTSTANDING SHARES OF KENVUE COMMON STOCK IN A CASH AND STOCK TRANSACTION THAT VALUES KENVUE AT AN ENTERPRISE VALUE OF APPROXIMATELY $48.7 BILLION, BASED ON THE CLOSING PRICE OF KIMBERLY-CLARK COMMON STOCK ON OCTOBER 31, 2025.

KIMBERLY-CLARK TO ACQUIRE KENVUE, CREATING A $32 BILLION GLOBAL HEALTH AND WELLNESS LEADER

SUMMIT, N.J.--(BUSINESS WIRE)--KENVUE INC. (NYSE: KVUE) TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS DECLARED A QUARTERLY DIVIDEND OF $0.2075 PER SHARE ON ITS COMMON STOCK. THE QUARTERLY DIVIDEND IS PAYABLE ON NOVEMBER 26, 2025, TO SHAREHOLDERS OF RECORD AS OF THE CLOSE OF BUSINESS ON NOVEMBER 12, 2025. ABOUT KENVUE KENVUE INC. IS THE WORLD'S LARGEST PURE-PLAY CONSUMER HEALTH COMPANY BY REVENUE. BUILT ON MORE THAN A CENTURY OF HERITAGE, OUR ICONIC BRANDS, INCLUDING AVEENO, BAND-AID BRAND, JOHN.

SUMMIT, N.J.--(BUSINESS WIRE)--KENVUE INC. (NYSE: KVUE) WILL ANNOUNCE ITS THIRD QUARTER 2025 FINANCIAL RESULTS BEFORE THE MARKET OPENS ON NOVEMBER 6, 2025. THE COMPANY WILL HOST A CONFERENCE CALL AND WEBCAST AT 8:30 A.M. EASTERN TIME TO DISCUSS ITS FINANCIAL RESULTS. THE CONFERENCE CALL CAN BE ACCESSED BY DIALING 877-407-8835 FROM THE U.S. OR +1 201-689-8779 FROM INTERNATIONAL LOCATIONS. A LIVE WEBCAST OF THE CONFERENCE CALL CAN ALSO BE ACCESSED AT INVESTORS.KENVUE.COM, WITH A REPLAY MADE AVAIL.

Kenvue Inc.

KVUE

Price

Financial Reports

No items found.

Press Releases

Kenvue Inc.

KVUE.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

KVUE